Ultragenyx Pharmaceutical reported $70K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Aptinyx Inc APTX:US $ 677K 0
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Bluebird Bio BLUE:US $ 0.74M 0.02M
Epizyme EPZM:US $ 0.02M 0M
Esperion Therapeutics ESPR:US $ 65K 4K
Insmed INSM:US $ 1.2M 6K
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Kyowa Hakko Kirin 4151:JP Y 26745M 0M
Macrogenics MGNX:US $ 0.62M 0M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Moderna Inc MRNA:US 39.2K 800
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 86K 0